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Engineering Deoxysugar Biosynthetic Pathways
from Antibiotic-Producing Microorganisms: A Tool
to Produce Novel Glycosylated Bioactive Compounds
In recent years, a number of 6DOHs gene clusters have
increasingly been characterized, most of them partici-
pating in the biosynthesis of different antibiotics pro-
duced by actinomycetes [5]. In a few cases, biosynthetic
gene clusters for the same 6DOHs have been character-
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ized from different producer organisms. This is the casede Asturias
for the D-desosamine gene cluster that has been char-Universidad de Oviedo
acterized from the erythromycin [6, 7], oleandomycin33006 Oviedo
[8, 9], pikromycin [10], and megalomicin [11] producerSpain
streptomycetes. Also the D-olivose gene cluster has
been cloned from the mithramycin [12, 13], urdamycin
[14], and landomycin [15] producers and the L-olean-
Summary drose cluster from the oleandomycin [8, 9] and avermec-
tin [16] producers. In spite of the increasing knowledge
A plasmid (pLN2) was generated in which genes in- about 6DOH biosynthesis, the isolation and purification
of nucleotide-activated sugars has been hampered be-volved in the biosynthesis of L-oleandrose in the
cause of instability and technological aspects. The earlyoleandomycin producer Streptomyces antibioticus
report by Schulman and coworkers on the isolation andATCC11891 were cloned. pLN2 was used to direct the
purification of dTDP-L-oleandrose from the avermectinbiosynthesis of different deoxysugars by exchanging
producer [17] was not followed by the purification ofand/or adding genes from other antibiotic biosynthetic
other NDP-activated sugars from producer organisms.clusters. Transfer of the synthesized deoxysugars to
The deoxysugars are transferred to the correspondingthe tetracenomycin C aglycon, 8-demethyl-tetraceno-
aglycon by glycosyltransferases, which are generallymycin C, through the use of the “sugar flexible” glyco-
sugar-, aglycon-, and site-specific. In recent years, in-syltransferase ElmGT, validated the system. Several
creasing evidence has suggested some degree of “flexi-pLN2 derivatives were constructed by replacement of
bility” of glycosyltransferases involved in the biosynthe-the oleU 4-ketoreductase gene by different 4-ketore-
sis of secondary metabolites, and there have been some
ductase genes. Some of them, such as EryBIV and reports of examples in which different deoxysugars have
UrdR, reduced the keto group of the 4-keto intermedi- been transferred by a glycosyltransferase to its aglycon
ates, generating L-olivosyl and D-olivosyl derivatives, [9, 13, 18–26]. One of these glycosyltransferases, the
respectively. The system was also used to generate an elloramycin glycosyltransferase (ElmGT), has been shown
L-rhamnosyl derivative (through a two-gene deletion) to be especially “flexible” in accepting different L- and
and an L-rhodinosyl derivative (through a combination D-deoxysugars and also being able to transfer a disac-
of a gene replacement and a gene addition). charide [24]. Recently, several plasmids that direct the
biosynthesis of either L-daunosamine [27], L-olivose [9],
L-oleandrose [9, 28] or D-desosamine [29] have beenIntroduction
reported. These plasmids contain different subsets of
genes involved in the biosynthesis of these deoxysugarsSugars are frequently structural components of natural
from several antibiotic-producing organisms.products. Important antibiotics (erythromycin), antifun-
Here we report the construction of a novel plas-gals (amphotericin B), antiparasites (avermectins), and
mid by using genes from L-oleandrose biosynthesis inanticancer drugs (doxorubicin) possess sugars attached
the oleandomycin producer Streptomyces antibioticusto the aglycon core. These sugar components usually
ATCC11891, which can be used as a “plug and play”participate in the molecular recognition of the cellular
system for the exchange of selected genes and substitu-target by the bioactive compound and, therefore, its
tion by homologous genes. It can thus potentially gener-presence is important, in many cases essential, for the
ate a great variety of deoxysugars. We also providebiological activity of many natural products [1]. A great
evidence of the formation of the different sugars throughmajority of these sugars belong to the 6-deoxyhexoses
the ability of the “sugar flexible” elloramycin glycosyl-(6DOHs). These sugars are synthesized from nucleoside
transferase, ElmGT, to transfer the newly synthesizeddiphosphate-activated hexoses (mainly D-glucose) via
sugars to the elloramycin aglycon 8-demethyl-tetracen-a 4-keto-6-deoxy intermediate. Two common enzymatic
omycin C.steps leading to the biosynthesis of this intermediate
are catalyzed by a dNDP-D-hexose synthase and dNDP-
D-hexose-4,6-dehydratase [2, 3]. The different 6DOHs Results and Discussion
will vary depending on the substituents and/or the ste-
reochemistry at carbon atoms at positions 2, 3, 4, or 5 Rationale behind the Selected Approach
of the hexose carbon chain, resulting from deoxygen- A great variety of 6DOHs are present in a large number
ations, transaminations, and/or C, N, or O methylations of bioactive natural products [1]. They can be grouped
[2, 3, 4]. D- and L-isomeric forms of many 6DOHs also on the basis of their isomer forms at carbon 5 in L-
exist as a result of the action of a 5- or a 3,5-epimerase. and D-sugars and also according to the deoxygenation
pattern of the different carbons [2–4, 30, 31]. We planned
to design a plasmid-based sugar-synthesizing system1Correspondence: jasf@sauron.quimica.uniovi.es
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constructs in E. coli and to transfer them into the Strep-
tomyces recipient host by protoplast transformation.
Finally, the plasmid had to include a promoter region
to control the transcription of the genes; we used the
erythromycin resistance gene promoter (ermEp*) from
Saccharopolyspora erythraea.
Construction of an L-Olivose-Synthesizing Cassette
Plasmid and Validation of the Assay System
A plasmid (pLN2) was constructed to serve as starting-
base material for the generation of different plasmids
capable of directing the biosynthesis of L-2,6-deoxysug-
ars (Figure 1). This plasmid was also designed in such
a way that it could be easily converted into a derivative
directing the biosynthesis of different L-6-deoxysugars
(see below). Seven genes (oleV, oleW, oleU, oleY, oleL,
oleS, and oleE) involved in the biosynthesis of the neutral
sugar L-oleandrose (ole genes) by Streptomyces antibi-
oticus, producer of the 14-membered macrolide olean-
domycin [8, 9], were used for the construction of this
plasmid (Table 1). Six out of the seven genes (oleV, oleW,
oleU, oleL, oleS, and oleE) code the enzymatic functions
that are necessary for the biosynthesis of NDP-L-olivoseFigure 1. Map of pLN2
[9], and the seventh one, oleY, codes for a 3-O-methyl-Only restriction sites flanking the different ole genes that were used
transferase responsible for the conversion of L-olivosefor subcloning are indicated. Abbreviations are as follows: PermE*,
into L-oleandrose late during oleandomycin biosynthe-erythromycin resistance promoter; tsr, thiostrepton resistance gene;
sis, in a step occurring after the transfer of L-olivose tobla, -lactamase gene: pUC18, replication origin of pUC18; pIJ101,
replication origin of pIJ101. the aglycon [32]. Three of the genes (oleL, oleS, and
oleE) were incorporated to the construct as a single DNA
fragment because they code for enzymes catalyzing the
three early and common steps in the biosynthesis of(“cassette plasmid”) that could be a useful genetic tool
for endowing different host strains with the capability all L-6-deoxysugars: activation of glucose-1-phosphate
into NDP-D-glucose (oleS), dehydration at carbons 4of synthesizing various 6DOHs. This plasmid would also
be useful for assaying potential activities and substrate and 6 (oleE), and epimerization at carbons 3 and 5 (oleL).
The rest of the genes were incorporated into the con-flexibility of different sugar biosynthetic gene products
by replacing selected genes from the plasmid with ho- struct as PCR-amplified DNA fragments flanked by
unique restriction sites not frequently found in Strepto-mologous counterparts. To acheive these goals, we
gave the plasmid several specific features. First, the myces DNA.
Due to the difficulties in detecting NDP-6DOH in livingdifferent sugar biosynthetic genes needed to be orga-
nized in such a way that they could be easily removed organisms, it was necessary to establish a system that
would allow the detection of the plasmid-directedand replaced (“plug and play system”) by other related
genes; for this reason, in this “cassette plasmid” the 6DOHs. This system consisted of detecting the forma-
tion of the NDP-6DOHs by their transfer to an aglycondifferent genes had to be cloned with unique and rare
restriction sites flanking each gene to facilitate its ex- and the subsequent formation of the corresponding gly-
cosylated compounds. For this purpose we developedchange. Second, we chose a bifunctional replicative
plasmid that would make it easy to create the different engineered host strains containing the appropriate gly-
Table 1. Genes Used for the Construction of the Different Plasmids
Gene Microorganism Antibiotic Sugar pathway Proposed function Reference
oleS S. antibioticus Oleandomycin L-oleandrose and glucose-1-phosphate: TTP [9]
D-desosamine thymidylyl transferase
oleE S. antibioticus Oleandomycin L-oleandrose and glucose 4,6-dehydratase [9]
D-desosamine
oleL S. antibioticus Oleandomycin L-oleandrose 3,5-epimerase [9]
oleV S. antibioticus Oleandomycin L-oleandrose 2,3-dehydratase [9]
oleW S. antibioticus Oleandomycin L-oleandrose 3-ketoreductase [9]
oleU S. antibioticus Oleandomycin L-oleandrose 4-ketoreductase [9]
oleY S. antibioticus Oleandomycin L-oleandrose 3-O-methyltransferase [8]
eryBIV Sacc. erythraea Erythromycin L-mycarose 4-ketoreductase [6, 7]
snogC S. nogalater Nogalamycin L-nogalose 4-ketoreductase AAF01815
urdZ3 S. fradiae Urdamycin A L-rhodinose 4-ketoreductase [14]
dnmV S. peucetius Daunorubicin L-daunosamine 4-ketoreductase [32]
tylD S. fradiae Tylosin 6-deoxy-D-allose 4-ketoreductase [33, 34]
urdR S. fradiae Urdamycin A D-olivose 4-ketoreductase [14]
urdQ S. fradiae Urdamycin A L-rhodinose 3,4-dehydratase [14]
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nous formation of the aglycon in the former case in
contrast to the exogenously added aglycon in the latter.
The conclusion from these experiments is that pLN2
was functional and directs the biosynthesis of L-olivose.
Consequently, this plasmid could now be used as a
starting point for further studies, including analysis of
the function of different sugar biosynthetic enzymes.
Assaying the Function and Substrate Flexibility
of Different Sugar 4-Ketoreductase Genes
by Single Gene Substitutions
In order to assay the versatility of the pLN2 “cassette
plasmid,” we replaced oleU by other genes that are also
reported to code 4-ketoreductases in other antibiotic
biosynthetic pathways but that act on different sugar
intermediates (Table 1; Figures 4 and 5). In a first step,
we chose eryBIV and snogC, which code 4-ketoreduc-
tases involved in the biosynthesis of erythromycin [6,
7] and nogalamycin (accesion number AAF01815). The
function of EryBIV was assigned after analysis of prod-
ucts accumulated by a strain with a mutation in its cod-
ing gene. EryBIV would catalyze the final 4-keto reduc-
tion step in the biosynthesis of L-mycarose [6, 7]. In the
case of SnogC, its function in L-nogalose biosynthesisFigure 2. Chemical Structure of 8-Demethyl-Tetracenomycin C and
has been proposed based on its similarity to knownthe Different Glycosylated Compounds Generated with the ElmGT
Glycosyltransferase and pLN2 Derivatives 4-ketoreductases. Although the three ketoreductases
(OleU, EryBIV, and SnogC) act on different intermedi-
ates, ketoreduction at C-4 occurs with the same stereo-
specificity (Figure 4). After replacement of oleU by ery-cosyltransferase gene. We took advantage of the “sugar
BIV (plasmid pLNBIV) a new HPLC peak appeared inflexibility” of the ElmGT glycosyltransferase from the
both host strains (16F4 and GB16), the conversion beingelloramycin pathway, which transfers different sugars
higher with 16F4 (20% for 16F4 and 3% for GB16). Theto the aglycon 8-demethyl-tetracenomycin C (8DMTC)
(Figure 2). Capable of transferring several L-6-deoxysug- compound was also identified as LOLV-TCMC by its
ars (L-olivose, L-rhamnose, L-rhodinose) and D-6- HPLC mobility, absorptium spectrum, and m/z values,
deoxysugars (D-olivose, D-mycarose) into 8DMTC [24, as shown previously for pLN2. The amounts of LOLV-
26], ElmGT has been shown to possess a “flexible” sub- TCMC formed were lower with pLNBIV than with pLN2.
strate specificity with respect to the sugar. We used This can be explained by the different natural substrates
two different approaches, providing the aglycon either of the OleU and EryBIV reductases. EryBIV would act
endogenously or exogenously. In the former, we used on a sugar biosynthetic intermediate (in L-mycarose bio-
S. albus 16F4, a recombinant strain harboring cosmid synthesis) with a hydroxyl group in axial configuration
16F4; this is a cosmid that directs the biosynthesis of and a methyl group in equatorial configuration at C-3,
8DMTC and also contains elmGT [24, 26]. In the latter, while OleU would act (in L-olivose biosynthesis) on an
we provided the aglycon by feeding S. albus GB16 with
unmethylated sugar intermediate with a hydroxyl group8DMTC; this is a recombinant strain in which elmGT is
in equatorial configuration at C-3. The fact that this lastintegrated into the chromosome and has its expression
intermediate is formed (in the presence of pLNBIV)under the control of ermEp [24].
would explain the difference in yields of LOLV-TCMC.To assay the functionality of pLN2, we transformed
The fact that eryBIV can be used to produce anstrains S. albus 16F4 and GB16 with pLN2. HPLC analy-
L-olivose-glycosylated derivative demonstrates a cer-sis showed that the new recombinant strain S. albus
tain degree of flexibility of this ketoreductase because16F4 (pLN2) produced a new compound that was pre-
it can act on both C-3-methylated and -unmethylatedsumed to be L-olivosyl-tetracenomycin C (LOLV-TCMC)
intermediates with different configurations of the hy-because of its HPLC mobility and absorption spectrum
droxyl group at C-3.when compared with those of the pure compound used
as a standard (Figure 3A). The same compound was Substitution of oleU by snogC (generating pLNS) did
detected after biotransformation of S. albus GB16 not generate any glycosylated compound after biotrans-
(pLN2) with 8DMTC. MALDI-TOF analysis of this com- formation with the aglycon 8DMTC. Because the ex-
pound showed molecular peaks at m/z 611.0815 and pected compounds would contain either an L-olivose
627.0728 for the sodium and potassium adducts of or an L-rhamnose moiety and these sugars have been
LOLV-TCMC, respectively. The efficiency of the forma- shown to be transferred by ElmGT, the absence of any
tion of LOLV-TCMC was much higher with strain 16F4 glycosylated compound indicates that the SnogC keto-
(64% of all 8DMTC formed was converted into the glyco- reductase did not act on the 4-keto intermediates that
sylated compound) than with strain GB16 (12% conver- could have been synthesized. The conclusion was that
SnogC has a narrower sugar-substrate specificity.sion). This difference can be explained by the endoge-
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Figure 3. HPLC Analysis of Cultures of Different Recombinant Strains Harboring pLN2 Derivatives and Producing 8DMTC Glycosylated
Compounds
(A) Strain harboring pLN2.
(B) Strain harboring pLNR.
(C) Strain harboring pLN2.
(D) Strain harboring pLNRHO.
We also assayed two other 4-ketoreductases, DnmV the three 6DOHs present in the macrolide antibiotic tylo-
sin [34, 35]. Strains 16F4 and GB16 harboring tylD (plas-and UrdZ3, which have different steroespecificity than
OleU and also act on different sugar intermediates (Fig- mid pLNT) did not produce any glycosylated product.
UrdR is a 4-ketoreductase involved in the biosynthesisures 4 and 5). DnmV is a 4-ketoreductase involved in
the biosynthesis of the aminosugar L-daunosamine in of D-olivose in urdamycin A biosynthesis by S. fradiae
[14]. In contrast to that of tylD, replacement of oleU byS. peucetius [33]. The UrdZ3 4-ketoreductase partici-
pates in the biosynthesis of the 2,3,6-trideoxysugar urdR led to the formation of a new glycosylated deriva-
tive (Figure 3B) with m/z values of 611.1532 andL-rhodinose, one of the sugars forming part of the angu-
cycline urdamycin A [14]. Provided that these two reduc- 627.1467 for the sodium and potassium adducts; these
values are equivalent to those obtained for LOLV-TCMCtases could recognize the pLN2-directed 4-keto inter-
mediate and because of the different stereoespecifity (see above). However, this compound showed an HPLC
retention different from that of LOLV-TCMC but had theat C-4 with respect to OleU, the formation of 2-deoxy-
L-fucose (L-oliose) instead of L-olivose (formed with the same absorption spectrum, suggesting its identity with
the D-isomer form, D-olivosyl-tetracenomycin C (DOLV-participation of OleU) should be expected when oleU
is replaced by either dnmV (plasmid pLNV) or urdZ3 TCMC). This was confirmed by comparison of its HPLC
mobility with that of pure DOLV-TCMC, used as a stan-(plasmid pLNZ3). Neither of the strains 16F4 or GB16
harboring either pLNV or pLNZ3 produced any new com- dard. Formation of DOLV-TCMC occurred with a high
efficiency (79%) in the case of strain 16F4. It is worthpound, suggesting that either L-oliose was not gener-
ated or, if it was, that it could not be recognized and to mentioning that this D-sugar was formed in the pres-
ence of the OleL 3,5-epimerase. To explain the formationtransferred by the ElmGT glycosyltransferase.
Two other 4-ketoreductases, TylD and UrdR, were of D-olivose, one must assume that NDP-4-keto-2,6-
dideoxy-D-glucose is a common intermediate in the bio-tested (Figures 4 and 5). Both act on different D-6-deox-
ysugar intermediates but have the same stereoespeci- synthesis of L- and D-olivose. In the case of L-olivose
biosynthesis (directed by pLN2), this 4-keto intermedi-ficity at C-4. TylD catalyzes a 4-keto reduction as the
final step in the formation of 6-deoxy-D-allose, one of ate would first be a substrate for the OleL 3,5-epimerase,
Deoxysugar Biosynthesis Plasmids
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of 659.0380, corresponding to elloramycin. The identity
of these compounds was also verified by comparison
with pure standards. Three conclusions can be drawn
from this experiment: (1) pLN2 contains all genes re-
quired for the biosynthesis of L-rhamnose; (2) the OleU
4-ketoreductase that naturally has as a substrate a 2,6-
dideoxy sugar intermediate in the biosynthesis of L-oli-
vose can also reduce a 6-deoxy intermediate, and (3)
although the OleL epimerase usually acts on 2,6-dideoxy
intermediates (see the above results for pLNR), it can
also recognize and epimerize a 6-deoxy intermediate.
We also attempted to construct another plasmid that
directs the biosynthesis of L-rhamnose. The two genes
(oleV and oleW) involved in the 2-deoxygenation step
were deleted from pLNBIV, a construct that has been
also shown to direct the biosynthesis of L-olivose (see
above). The resultant construct (pLNBIV) was intro-
duced in S. albus 16F4 and S. albus GB16 and assayed
for the potential formation of 8DMTC glycosylated deriv-
atives. In both cases, no glycosylated derivatives were
formed. This result indicates that, in contrast to OleU,
which was able to reduce a 6-deoxy intermediate (see
above), EryBIV did not recognize that intermediate. This
suggests that EryBIV probably requires a C-2-deoxyge-
nated sugar intermediate for its action.
Figure 4. Enzymatic Steps Catalyzed by the Different 4-Ketoreduc-
tases Used in this Study
Combining Gene Replacement and Gene Addition
to Design a Construct that Directs the
Biosynthesis of L-Rhodinoseand the OleU reductase would reduce the resulting
L-olivose and L-rhodinose are 6DOHs that differ in the4-keto product (Figure 6). However, when oleU was re-
hydroxyl groups at C-3 and C-4; L-olivose is a 2,6-dide-placed by urdR (plasmid pLNR), the NDP-4-keto-2,6-
oxysugar with an equatorial hydroxyl group at C-4, anddideoxy-D-glucose would be diverted by the UrdR keto-
L-rhodinose is a 2,3,6-trideoxysugar with an axial hy-reductase, generating D-olivose (Figure 6).
droxyl at C-4. To design a plasmid that directs the bio-
synthesis of L-rhodinose, we used pLN2 as starting con-Designing a Construct Directing the Biosynthesis
struct to first replace the ketoreductase oleU by anotherof the 6DOH L-Rhamnose by Two-Gene Deletion
ketoreductase able to direct the reduction step withL-Rhamnose and L-olivose are two 6DOHs that only
different stereochemistry. This was already achieved indiffer in the oxygenation state at C-2; L-rhamnose con-
the previous construct, pLNZ3 (see above). Next, it wastains a hydroxyl group, and L-olivose does not. Because
necessary to add a second gene coding for a 3,4-dehy-pLN2 was designed in such a way that one can easily
dratase. For this purpose we chose urdQ from the urda-delete the genes involved in the 2-deoxygenation step
mycin biosynthetic cluster [14]. The final construct(oleV and oleW), we were able to create a derivative of
(pLNRHO) was used to transform protoplasts of the re-pLN2 by deleting these two genes. The resultant con-
cipient host strains 16F4 and GB16. A new compoundstruct (plasmid pLN2) should direct the biosynthesis
was formed (Figure 3D). MALDI-TOF analysis in the neg-of the 6DOH L-rhamnose. These two genes were re-
ative mode showed an m/z value of 571.0760, which ismoved by digestion of pLN2 with AvrII and SpeI and
consistent with the formation of L-rhodinosyl-tetraceno-further religation (these enzymes generate compatible
mycin C (LRHO-TCMC). HPLC analysis also showed thiscohesive ends). The final construct (pLN2) was intro-
compound to have mobility identical to that of pureduced into strains 16F4 and GB16, and the formation
LRHO-TCMC, which was used as a standard.of glycosylated derivatives was analyzed by HPLC and
MALDI-TOF. 8DMTC was efficiently converted into gly-
cosylated compounds (Figure 3C). In the case of strain Discussion
16F4, 8DMTC was converted into elloramycin because,
once L-rhamnose is transferred by ElmGT, the three Sugars contribute to the structural biodiversity of natural
products. Moreover, biological activity of many of theseO-methyltransferases present in cos16F4 methylate the
free hydroxyl groups of L-rhamnose [36]. MALDI-TOF compounds is dependent on the sugar moieties, which
constitute an important part of the molecule in its inter-analysis of the glycosylated compound formed by strain
GB16 showed molecular peaks at m/z values of 627.0641 action with the drug target site. Changing the sugar
moieties in natural products might be an important con-and 643.0388 for the sodium and potassium adducts,
which is consistent with the formation of LRHA-TCMC. tribution to the generation of novel derivatives with po-
tentially new pharmacological properties. Some studiesIn the case of strain 16F4, MALDI-TOF analysis in the
negative mode showed a molecular peak at an m/z value have reported plasmids that direct the biosynthesis of
Chemistry & Biology
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Figure 5. Organization of ole Genes in pLN2 and Plasmid-Borne Constructs Derived from pLN2
Black triangles indicate the erythromycin resistance promoter. Red arrows indicate genes substituting ole genes in the different constructs.
Abbreviations are as follows: Av, AvrII; Hp, HpaI; Nh, NheI; Pc, PacI; Sp, SpeI; Sh, SphI; Xb, XbaI.
different 6DOHs [9, 27–29]. These plasmids were gener- D-glucose intermediate is a common biosynthetic inter-
mediate to both L- and D-olivose.ated through subcloning DNA regions from the chromo-
some of different antibiotic-producing streptomycetes A second utility of this plasmid is the incorporation
of new enzymatic functions through the insertion of ad-into appropriate plasmid vectors. The plasmid construct
reported in this work (pLN2) confers to the recipient ditional genes. This is facilitated by the presence of
several unique restriction sites in these plasmids. Thishost strains the capability of synthesizing L-olivose in its
NDP-activated form. Furthermore, it possesses several is exemplified by the generation of pLNRHO in which,
in addition to exchange of the 4-ketoreductase gene, aimportant technological advantages over the others.
First, some of the genes are flanked by restriction sites new gene function was incorporated (a 3,4-dehydratase)
in order to direct the biosynthesis of L-rhodinose. Anfor enzymes that do not frequently recognize streptomy-
cetes DNA, so they can be easily replaced by homolo- additional advantage of pLN2 is the simplicity of con-
verting 2,6-deoxysugars into 6-deoxysugars by a singlegous genes. This allows an assay of the specific function
of selected genes (and their products) and makes it two-gene deletion. This utility was proven by the genera-
tion of pLN2 from pLN2 and the consequent biosynthe-possible to test the flexibility of the sugar biosynthetic
enzymes in recognizing different biosynthetic intermedi- sis of L-rhamnose instead of L-olivose.
These plasmids are also important tools for producingates. In this work, we have tested the “flexibility” of
different 4-ketoreductases and found that some of them novel glycosylated compounds within recipient hosts.
In this work, we have taken advantage of the sugarpossess a certain degree of flexibility with respect to
the sugar substrate. An example from the erythromycin flexibility of the ElmGT glycosyltransferase to produce
several glycosylated tetracenomycin derivatives con-pathway is the EryBIV ketoreductase, which has been
shown to reduce the 4-keto group at C-4 and to react taining L-rhamnose, L-olivose, L-rhodinose, and D-oli-
vose. These compounds were previously reported towith different stereochemistry on both C-3-methylated
and -unmethylated intermediates, independently of the be produced by antibiotic-producing microorganisms
containing a cosmid clone conducting the biosynthesisstereochemistry of the hydroxy group at C-3. In some
cases, a single gene exchange was sufficient to gener- of 8DMTC and having the endogenous capability of syn-
thesizing these sugars [24, 26, 37]. Here we show aate a different sugar. This was the case for the substitu-
tion of urdR for oleU, both coding 4-ketoreductases. novel approach that can be used to produce these com-
pounds in antibiotic-producing and antibiotic-nonpro-Interestingly, the starting construct (pLN2) directs the
biosynthesis of an L-6-deoxysugar, and through this ducing microorganisms through the incorporation of
specific constructs directing sugar biosynthesis. Al-substitution, a D-6-deoxysugar was formed. An explana-
tion to this fact would be that the NDP-4-keto-2,6-dideoxy- though in the present work these constructs have been
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Figure 6. Proposed Pathways for the Biosyn-
thesis of the Different NDP-Activated Deoxy-
sugars Generated in this Work
galater NRRL3035 (nogalamycin producer), Streptomyces fradiaeused to produce glycosylated tetracenomycin deriva-
Tu¨2717 (urdamycin producer), and Saccharopolyspora erythraeatives, the potential of pLN2 derivatives is not restricted
NRRL2338 (erythromycin producer) were used as sources of DNA.to this system. Recent experiments in our laboratory
Streptomyces albus GB16 [24] and S. albus 16F4 (this work) were
have shown that combining pLN2 derivatives with the used as hosts for gene expression and for biotransformation experi-
EryBV L-mycarosyl glycosyltransferase from the eryth- ments. Streptomyces argillaceus 16F4 [24] was used for obtaining
romycin pathway can lead to the production of different 8-demethyl-tetracenomycin C (8DMTC). Growth was carried out on
trypticase soya broth (TSB; Oxoid) or R5A medium [38]. For sporula-monoglycosylated macrolides (N.A., unpublished data).
tion, growth was for 7 days at 30C on agar plates containing A
medium [38]. Escherichia coli XL1-Blue [39] was used as a host forSignificance
subcloning and was grown at 37C in TSB medium. pLITMUS29
(Biolabs) and pUC18 were used as vectors for subcloning experi-
Increasing evidence suggests the existence of a rela- ments and DNA sequencing. pWHM3 [40] and pEM4 [41] were used
tive sugar substrate flexibility in antibiotic biosynthe- for expression in Streptomyces. When antibiotic selection of trans-
formants was needed, 25 g/ml of thiostrepton, 25 g/ml of apra-sis glycosyltransferases. pLN2 (and derivatives) can
mycin, or 100 g/ml of ampicillin were used.serve to engineer antibiotic-producing strains to en-
dow them with the capability of synthesizing different
6DOHs. These plasmids can also be introduced in non-
DNA Manipulation and Sequencing
producing strains to be used as biotransformation re- Plasmid DNA preparations, restriction endonuclease digestions, al-
cipient hosts to generate novel glycosylated deriva- kaline phosphatase treatments, ligations, and other DNA manipula-
tives. The use of these plasmids will facilitate the assay tions were according to standard procedures for E. coli [42] and for
Streptomyces [43]. Sequencing was performed via the dideoxy-of substrate flexibility of glycosyltransferases.
nucleotide chain termination method [44] and the Cy5 AutoCycle
Sequencing Kit (Pharmacia Biotech). Both DNA strands were se-Experimental Procedures
quenced with primers supplied in the kits or with internal oligoprimers
(17-mer) via an ALF-express automatic DNA sequencer (Pharmacia).Microorganisms, Culture Conditions, and Vectors
Computer-assisted database searching and sequence analyses wereStreptomyces antibioticus ATCC11891 (oleandomycin producer),
carried out with the University of Wisconsin Genetics Computer GroupStreptomyces fradiae ATCC19609 (tylosin producer), Streptomyces
peucetius ATCC29050 (daunorubicin producer), Streptomyces no- programs package [45] and the BLASTP program [46].
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